Paladin chief commits to the future, but what of the company's?

Tumbling uranium prices spell trouble for this business.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Uranium producer and explorer Paladin Energy (ASX: PDN) has extended chief executive's John Borschoff's tenure by a further year until 31 December 2014. There's an option for the agreement to be extended a further two years depending on performance. Executive salaries across the company have been reduced or frozen recently as it battles incredibly tough market conditions.

The company has also been in investors' sights due to consistently disappointing past performance. In fact fellow Fool Tim McArthur highlighted in this excellent article how the Australian Shareholders Association (ASA) identified Paladin chairman Rick Crabb as under pressure himself. The ASA pointed to US$1.3 billion of accumulated losses over the past 19 years and no dividend payment since 1994.

The share price has been in freefall as the company faced a perfect storm of tumbling uranium prices, substantial asset impairments and a global inclination to move away from nuclear as a power source. In fact the company's recent problems can be traced directly back to the earthquake and subsequent Fukushima nuclear crisis that struck Japan in March 2011.

The company posted a full-year loss of US$474 million in August and has embarked on a significant cost-cutting plan to try and save $60 million over two years. It continues to carry significant balance sheet debt and needs to see a uranium price recovery sooner rather than later.

Foolish takeaway

Persistent uranium price weakening represents a threat — not just to companies like Paladin but to worldwide production of uranium in general. The nuclear economies have taken a hit post-Fukushima as nation-states reconsider the strengths and weaknesses of nuclear power. If the uranium price fall proves a long-term trend rather than short-term reactio,n companies like Paladin face some gale-force headwinds.

Motley Fool contributor Tom Richardson does not own shares in any of the companies mentioned in this article. 

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »